Journal ArticleOPEN ACCESS

Drug-Development Challenges for Small Biopharmaceutical Companies

  • Moscicki R
  • Tandon P
New England Journal of Medicine (2017) 376(5) 469-474
DOI: 10.1056/nejmra1510070
14Citations
Citations of this article
200Readers
Mendeley users who have this article in their library.

Abstract

f. Has examples of strategies in PD, Cystic Fibrosis, Pompe, and discusses importance of rigor

Cite

CITATION STYLE

APA

Moscicki, R. A., & Tandon, P. K. (2017). Drug-Development Challenges for Small Biopharmaceutical Companies. New England Journal of Medicine, 376(5), 469–474. https://doi.org/10.1056/nejmra1510070

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free